Sarilumab in Patients With Glucocorticoid-Dependent Sarcoidosis

Clinical Trials

Institution: Stanford University

Type: Individual Site


The purpose of this study is to compare the effectiveness and the safety of sarilumab in patients with glucocorticoid-dependent sarcoidosis. To demonstrate that sarilumab treatment will be effective for inducing and maintaining glucocorticoid-free remission in male or female patients with biopsy proven active, glucocorticoid-dependent sarcoidosis affecting the lungs, lymph nodes, liver, kidneys, spleen, bone, soft tissues, skin, and/or eyes.

Dates: September 5, 2019 - July 1, 2025

Disease: Pulmonary Fibrosis



Matthew Baker
[email protected]

Page last updated: February 23, 2021

Freedom From Smoking Clinic
Brooklyn, CT | May 31, 2022
Freedom From Smoking - Cleveland, OH Virtual Event
Cleveland, OH | Jun 02, 2022